cetus corp. said 0 the government of spain approved the marketing of its proleukin interleukin-2 drug 0 to treat kidney cancer . the biotechnology concern said 0 spanish authorities must still clear the price for the treatment , but that it expects to receive such approval by year end . four other countries in europe have approved proleukin in recent months . cetus is currently trying to obtain federal regulatory clearance for u.s. distribution .